ZymoGenetics
Seattle
About ZymoGenetics
ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Total funding: $197.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2010)
- Ticker: nasdaq:ZGEN
- Website: zymogenetics.com
- Phone: +1 (206)442-6600
Industries & Categories
Alternative Protein, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zymogenetics-3019240 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.